Home > Share Market > Stocks > Glaxosmithkline pharmaceuticals > Financial Statements> GLAXO Profit & Loss

Glaxosmithkline Pharmaceuticals Ltd Financial Statements

Profit & Loss Statement of Glaxosmithkline Pharmaceuticals Ltd

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2022 Mar-2021 Mar-2020 Mar-2017
Revenue 3,278 2,926 3,224 2,908
yoy growth (%) 12 (9.30) 10.90 2.49
Raw materials (1,356) (1,257) (1,308) (1,398)
As % of sales 41.40 43 40.60 48.10
Employee costs (610) (616) (629) (483)
As % of sales 18.60 21.10 19.50 16.60
Other costs (550) (454) (631) (609)
As % of sales 16.80 15.50 19.60 20.90
Operating profit 762 598 657 419
OPM 23.20 20.40 20.40 14.40
Depreciation (68) (79) (83) (26)
Interest expense (2) (3.50) (6.30) (0.30)
Other income 75.80 111 79 73.10
Profit before tax 767 627 647 465
Taxes (398) (167) (213) (174)
Tax rate (52) (27) (33) (37)
Minorities and other 1,314 70.90 -- --
Adj. profit 1,683 531 435 291
Exceptional items 11.60 (173) (341) 45.70
Net profit 1,695 358 93.20 337
yoy growth (%) 373 284 (72) (10)
NPM 51.70 12.20 2.89 11.60

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000